Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rang in Aktien #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Aktienkurs
$0.00185055
Marktkapitalisierung
$48.29K
Veränderung (1 Tag)
-3.55%
Veränderung (1 Jahr)
30.31%
Land
GB
Handel Nuformix plc (NFX)

Kategorie

Kursverlauf für Nuformix plc (NFX)
Höchster Schlusskurs: $0.00 am 2026-09-01

Niedrigster Schlusskurs: $0.04 am 2015-12-01
Kursverlauf der Aktie von Nuformix plc von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 410.64%
2024 -82.59%
2023 -11.19%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$514.89 35.60%
US
$182.73 608.53%
US
$125.92 -4.58%
AU
$948.14 29.11%
NL
$730.39 7.23%
CH